Fig 4 -

<div><p>Coinfection with human papillomavirus (HPV) and HIV compounds the risks of developing cervical, anal, and HPV-associated oral neoplasia. Safe prophylactic vaccines are available to prevent HPV infections in people with HIV(PWH). Yet, vaccine efficacy and duration of protection re...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Alvine M. Akumbom (20460907) (author)
مؤلفون آخرون:	Alanna J. Bergman (14551967) (author), Howard Strickler (4510189) (author), Chakra Budhathoki (4333303) (author), Manka Nkimbeng (9916716) (author), Raeven Grant (20460910) (author), Nancy R. Reynolds (9692588) (author), Kawsar R. Talaat (9721230) (author)
منشور في:	2024
الموضوعات:	Medicine Biotechnology Immunology Cancer Science Policy Infectious Diseases Virology Computational Biology xlink "> coinfection hedges &# 8217 applying existing evidence 43 ), respectively hpv vaccine trials safe prophylactic vaccines random effects meta protection remain questionable prevent hpv infections meaningful clinical outcomes hpv18 seropositivity cut associated oral neoplasia hpv vaccine efficacy people without hiv analysis </ p vaccine efficacy persistent infections oral lesions systematic review significantly lower sexual debut sex differences secondary outcome risk factors qualitatively synthesized people living mean difference included enrollees human papillomavirus hpv18 genotypes hiv compounds early age defining illness cell count baseline cd4 assuming milli assess age 500 cells 400 copies
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Fig 4 -

مواد مشابهة